Erratum: Overexpression of leukocyte marker CD43 causes activation of the tumor-suppressor proteins p53 and ARF (Oncogene (2004) 23 (2523-2530) DOI: 10.1038/sj.onc.1207359);Overexpression of leukocyte marker CD43 causes activation of the tumor suppressor proteins p53 and ARF

Oncogene

Volumn 23, Issue 14, 2004, Pages 2523-2530

  Kadaja, Lilian ^a   Laos, Sirle ^b   Maimets, Toivo ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

CD43; p19ARF; p53

Indexed keywords

ARF PROTEIN; LEUKOSIALIN; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; EMBRYO; EMBRYO CELL; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALIA;

EID: 1942436863     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207745     Document Type: Erratum

References (54)

1. Andersson LC and Gahmberg CG. (1978). Blood, 52, 57-67.
2. Ardman B, Sikorski MA and Staunton DE. (1992). Proc. Natl. Acad. Sci. USA, 89, 5001-5005.
3. Axelsson B, Youseffi-Etemad R, Hammarstrom S and Perlmann P. (1988). J. Immunol., 141, 2912-2917.
4. Baeckstrom D, Hansson GC, Nilsson O, Johansson C, Gendler SJ and Lindholm L. (1991). J. Biol. Chem., 266, 21537-21547.
5. Baeckstrom D, Zhang K, Asker N, Ruetschi U, Ek M and Hansson GC. (1995). J. Biol. Chem., 270, 13688-13692.
6. Bates S, Phillips A, Clark P, Stott F, Peters G, Ludwig R and Vousden K. (1998a). Nature, 395, 124-125.
7. Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL and Vousden KH. (1998b). Nature, 395, 124-125.
8. Carlsson SR and Fukuda M. (1986). J. Biol. Chem., 261, 12779-12786.
9. Damalas A, Ben-Ze'ev A, Simcha I, Shtutman M, Leal JF, Zhurinsky J, Geiger B and Oren M. (1999). EMBO J., 18, 3054-3063.
10. Damalas A, Kahan S, Shtutman M, Ben-Ze'ev A and Oren M. (2001). EMBO J., 20, 4912-4922.
11. de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ and Lowe SW. (1998). Genes Dev., 12, 2434-2442.
12. Dragone LL, Barth RK, Sitar KL, Disbrow GL and Frelinger JG. (1995). Proc. Natl. Acad. Sci. USA, 92, 626-630.
13. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
14. Fearon E and Vogelstein B. (1990). Cell, 61, 759-767.
15. Fernandez-Rodriguez J, Andersson CX, Laos S, Baeckstrom D, Sikut A, Sikut R and Hansson GC. (2002). Tumour Biol., 23, 193-201.
16. Giaccia AJ and Kastan MB. (1998). Genes Dev., 12, 2973-2983.
17. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. (1993). Cell, 75, 805-816.
18. Joers A, Kristjuhan A, Kadaja L and Maimets T. (1998). Oncogene, 17, 2351-2358.
19. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
20. Kubbutat MH and Vousden KH. (1998). Mol. Med. Today, 4, 250-256.
21. Lane D and Hall P. (1997). Trends Biochem. Sci., 22, 372-374.
22. Levine AJ. (1997). Cell, 88, 323-331.
23. Lowe SW and Sherr CJ. (2003). Curr. Opin. Genet. Dev., 13, 77-83.
24. Mazars R, Pujol P, Maudelonde T, Jeanteur P and Theillet C. (1991). Oncogene, 6, 1685-1690.
25. Meek DW. (1998). Cell Signal., 10, 159-166.
26. Mentzer SJ, Remold-O'Donnell E, Crimmins MA, Bierer BE, Rosen FS and Burakoff SJ. (1987). J. Exp. Med., 165, 1383-1392.
27. Miura Y, Mizutani C, Nishihara T, Hishita T, Yanagi S, Tohyama Y, Ichiyama S, Yamamura H, Uchiyama T and Tohyama K. (2001). Biochem. Biophys. Res. Commun., 288, 80-86.
28. Ostberg JR, Dragone LL, Driskell T, Moynihan JA, Phipps R, Barth RK and Frelinger JG. (1996). J. Immunol., 157, 4876-4884.
29. Palmero I, Pantoja C and Serrano M. (1998). Nature, 395, 125-126.
30. Park JK, Rosenstein YJ, Remold-O'Donnell E, Bierer BE, Rosen FS and Burakoff SJ. (1991). Nature, 350, 706-709.
31. Pedraza-Alva G, Merida LB, Burakoff SJ and Rosenstein Y. (1998). J. Biol. Chem., 273, 14218-14224.
32. Persons DL, Yazlovitskaya EM and Pelling JC. (2000). J. Biol. Chem., 275, 35778-35785.
33. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA. (1998). Cell, 92, 713-723.
34. Prives C and Hall PA. (1999). J. Pathol., 187, 112-126.
35. Reich N, Oren M and Levine A. (1983). Mol. Cell. Biol., 3, 2143-2150.
36. Remold-O'Donnell E, Kenney DM, Parkman R, Cairns L, Savage B and Rosen FS. (1984). J. Exp. Med., 159, 1705-1723.
37. Rogel A, Popliker M, Webb C and Oren M. (1985). Mol. Cell. Biol., 5, 2851-2855.
38. Rosenstein Y, Santana A and Pedraza-Alva G. (1999). Immunol. Res., 20, 89-99.
39. Sambrook J, Fritsch EF and Maniatis T. (1989). Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press: Cold Spring Harbour, NY.
40. Santamaria M, Lopez-Beltran A, Toro M, Pena J and Molina IJ. (1996). Cancer Res., 56, 3526-3529.
41. Santana MA, Pedraza-Alva G, Olivares-Zavaleta N, Madrid-Marina V, Horejsi V, Burakoff SJ and Rosenstein Y. (2000). J. Biol. Chem., 275, 31460-31468.
42. Sherr CJ. (1996). Science, 274, 1672-1677.
43. Sherr CJ and Weber JD. (2000). Curr. Opin. Genet. Dev., 10, 94-99.
44. Sikut R, Andersson CX, Sikut A, Fernandez-Rodriguez J, Karlsson NG and Hansson GC. (1999). Int. J. Cancer, 82, 52-58.
45. Sikut R, Nilsson O, Baeckstrom D and Hansson GC. (1997). Biochem. Biophys. Res. Commun., 238, 612-616.
46. Stewart ZA and Pietenpol JA. (2001). Breast Cancer Res., 3, 5-7.
47. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G. (1998). EMBO J., 17, 5001-5014.
48. Tanaka M and Herr W. (1990). Cell, 60, 375-386.
49. Wang W, Link V and Green JM. (2000). Cell Immunol., 205, 34-39.
50. Wang S and Shi X. (2001). Carcinogenesis, 22, 757-762.
51. Weinberg RA. (1997). Cell, 88, 573-575.
52. Wu X, Bayle JH, Olson D and Levine AJ. (1993). Genes Dev., 7, 1126-1132.
53. Zhang Y, Xiong Y and Yarbrough W. (1998). Cell, 92, 725-734.
54. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF. (1998). Genes Dev., 12, 2424-2433.